No abstract available
MeSH terms
-
Coronary Restenosis / prevention & control*
-
Drug-Eluting Stents / adverse effects*
-
Female
-
Humans
-
Immunosuppressive Agents / adverse effects*
-
Male
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Sirolimus / analogs & derivatives*
-
Sirolimus / therapeutic use
-
Thienopyridines / therapeutic use*
Substances
-
Immunosuppressive Agents
-
Platelet Aggregation Inhibitors
-
Thienopyridines
-
zotarolimus
-
Sirolimus